Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6200906 | 0.81 | — | — | |
| SCHEMBL28841090 | 0.75 | PTGS2 (0.41) | ESR1 | |
| SCHEMBL15709893 | 0.75 | PTGS2 (0.41) | ESR1 | |
| SCHEMBL7809407 | 0.75 | — | — | |
| SCHEMBL17785186 | 0.75 | PTGS2 (0.41) | ESR1 | |
| SCHEMBL771242 | 0.75 | PTGS2 (0.41) | ESR1 | |
| SCHEMBL14839942 | 0.74 | PTGS2 (0.40) | ESR1 | |
| SCHEMBL21808122 | 0.73 | NR5A1 (0.40) | — | |
| SCHEMBL937881 | 0.71 | NPC1 (0.37) | — | |
| SCHEMBL22400745 | 0.70 | LMNA (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2068379-B1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR DEVICE USING THE SAME, AND THEIR PRODUCTION METHODS | UNIV HIROSHIMA (JP) | 2012-12-26 | — | — | EP | disclosed |
| EP-2068379-A1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR DEVICE USING THE SAME, AND THEIR PRODUCTION METHODS | Hiroshima University (JP) | 2009-06-10 | — | — | EP | disclosed |
| US-20090069384-A1 | THIENOPYRROLES USEFUL IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2009-03-12 | — | — | US | disclosed |
| EP-1844051-A1 | THIENOPYRROLES USEFUL IN THE TREATMENT OF INFLAMMATION | Biolipox AB (SE) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006077412-A1 | THIENOPYRROLES USEFUL IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069384-A1 | THIENOPYRROLES USEFUL IN THE TREATMENT OF INFLAMMATION | NPY5R, TH, PTGES | DAO 1850/4885ESR1 1760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.